Best Practices in the Diagnosis and Management of Homozygous Familial Hypercholesterolemia: Towards Individualized Treatment Strategies is organized by Healio, Horizon CME.
Release Date: November 9, 2023
Expiration Date: November 9, 2024
Program Description
This roundtable discussion with expert faculty will provide learners with the latest advances in diagnosing and managing patients with Homozygous Familial Hypercholesterolemia (HoFH). The goal of the activity is for learners to be better able to recognize the signs and symptoms of HoFH, the diagnostic criteria for this disease, the recommendations for cascade screening, as well as current strategies for individualizing treatment of HoFH in children and adults, including a review of angiopoietin-like 3 (ANGPTL3) inhibitors and it’s role in the management of HoFH.
Educational Objectives
Upon completion of the educational activity, participants should be able to:
• Implement strategies for the timely diagnosis of HoFH
• Discuss the role of cascade screening in identifying patients with HoFH
• Integrate current approved therapies for the treatment of HoFH
• Individualize treatment for patients with HoFH based on response to therapy and/or disease genetics